1. National Institute for Health and Care Excellence. Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: technology appraisal guidance. [TA733]. 2021. https://www.nice.org.uk/guidance/ta733/documents/html-content-2
2. National Institute for Health and Care Excellence. NICE approves ground-breaking cholesterol-lowering drug inclisiran. Press release, 1 Sep 2021. https://www.nice.org.uk/news/article/nice-approves-ground-breaking-cholesterol-lowering-drug-inclisiran
3. Glover E. Inclisiran: the ‘game-changer’ cholesterol drug to be offered on NHS. Independent 2021 Sep 2. https://www.independent.co.uk/news/health/cholesterol-drug-inclisiran-nhs-b1912298.html
4. National Institute for Health Research. Life-saving anti-cholesterol drug recommended on NHS thanks to groundbreaking clinical trials. 2021. https://www.nihr.ac.uk/news/life-saving-anti-cholesterol-drug-recommended-on-nhs-thanks-to-groundbreaking-clinical-trials/28584
5. Demasi M. ‘Ground-breaking’ cholesterol jab needs a rethink. 2021. https://maryannedemasi.com/blog/f/%E2%80%9Cground-breaking%E2%80%9D-cholesterol-jab-needs-a-rethink